Proceedings of the 51st Hawaii International Conference on System Sciences | 2018

Can a Hospital’s Analytics Capabilities Impact Patient Satisfaction?
A Multi-Year Panel Study
Idris Adjerid
University of Notre Dame
iadjerid@nd.edu

Corey M. Angst
University of Notre Dame
cangst@nd.edu

Abstract
An empirical link between organizational
performance and the IT necessary to enable data
analytics capabilities has not yet been established.
Drawing from organization information processing
theory (OIPT), which argues that uncertainty and
equivocality
negatively
impact
organizational
performance, we construct a model in which
performance—measured
as
hospitals’
patient
satisfaction—is a function of clinical analytics
capabilities, complexity, and concentration. Our
argument is that clinical analytics is an uncertaintyreducing mechanism that directly impacts satisfaction.
However, we propose a nuanced moderating role of
complexity of patient cases and concentration (the mix
of procedures performed in a hospital). We show that
analytics capabilities increased patient satisfaction, but
we also find evidence for the moderating role of
complexity on the effect of analytics on satisfaction. The
result for the moderating impact of concentration was
not significant; however, our post-hoc analysis
indicated that the moderating effect was present in
larger hospitals.

1. Introduction
Organizations possess knowledge and use it to solve
problems [1, 2], but certain situations are known to arise
in which the knowledge required to complete a task is
either not contained within the boundaries of the firm or
not readily accessible in a useable format. The dramatic
surge in recent years of both data analytics capabilities
and organizational investment in these capabilities
represents a significant step forward in bridging the gap
between the knowledge required for organizations to
perform optimally and what is readily available to them
in practice. Despite there being little doubt that analytics
is an IT-related phenomenon, surprisingly few studies
have identified how or where analytics fits into IT
research. In particular, whether and how the IT artifacts
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associated with analytics capabilities create value is
particularly unclear [3-5]. We address this gap in the
context of healthcare where investments in clinical and
administrative technologies over the last two decades
have resulted in hospitals with enormous stores of data
that could yield potentially significant insights. This has
spurred hospitals to increasingly adopt healthcare
analytics (HA), or systems that extract and analyze data
from other health IT systems to generate potentially
useful clinical and operational insights (we provide
examples of the operationalization of this later in the
paper).
As in other industries, the potential benefits of HA
in healthcare are substantial, but the link between the
capabilities HA provides and hospital performance has
not yet been theoretically explored or empirically
validated. This is relevant since widespread or uniform
gains in hospital performance as a result of HA
adoption are by no means a foregone conclusion. A
common theme of decades of IT value research
(including work in healthcare) highlights that
technology investments are rarely silver bullets where
simply “turning on” the system is sufficient to realize
promised gains. Rather, firms have to invest heavily in
learning and training, exploit the complementarities,
and reorganize process and workflows to accommodate
IT investments [6-11]. In relation to healthcare
specifically, a number of studies identify heterogeneous
and nuanced effects of health IT adoption on health
outcomes [e.g., 12, 13-15]. This body of work suggests
that even if value does accrue from HA, it is unlikely
that this value accrues homogenously across healthcare
settings and hospitals.
In this paper, we use Organizational Information
Processing Theory (OIPT) to investigate whether this
relatively early-stage adoption of HA can improve
hospital performance, and if so, what factors might
moderate this effect. Specifically, we evaluate the
impact of HA on hospitals’ patient satisfaction, which
is both of high importance to hospitals and could
reasonably be impacted by adoption of HA. For
example, patient satisfaction may be impacted as a
function of better care—and also independent of care,
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if patients perceive that care supplemented by HA is
more accurate or customized to them [16]. Aside from
influencing and supplementing patient interactions,
analytics may be applied to historic data on patient
satisfaction to identify important predictors of high
quality care [16].
OIPT is a particularly useful framework for
investigating the impact of HA on patient satisfaction
since it posits that reducing uncertainty—and when
present, equivocality (ambiguity)—in decision making
is key to improving performance. Along these lines, we
contend that in healthcare environments generally
replete with decision uncertainty [17, 18], HA will
improve patient satisfaction, on average, because of its
significant potential to resolve this uncertainty.
Consistent with OIPT, we also argue that these effects
may emerge unevenly because HA may not as
effectively reduce equivocality in decision making,
again when such equivocality is present. In addition to
arguments in the extant literature suggesting that
information systems are less useful for resolving
equivocality, relative to uncertainty [19], current HA
tools are still nascent and provide basic analytics
capabilities [20]. More advanced HA capabilities (e.g.,
real-time generation of clinical insights and diagnoses)
are both rare and hampered by lack of trust and
acclimatization on the part of providers [21].
It follows then that clinical settings where resolution
of equivocality is central to driving gains in patient
satisfaction would benefit less from the adoption of
healthcare analytics that reduce uncertainty in decision
making. We consider two factors that moderate whether
resolution of equivocality is central to driving gains in
patient satisfaction: the clinical complexity of patients
seen and hospitals’ clinical concentration (the mix of
procedures performed in a hospital, with higher
concentration indicating that the hospital allocates a
significant portion of its resources to a smaller number
of clinical areas). We argue that these factors moderate
the relationship between HA and patient satisfaction
because hospitals with higher patient complexity and
those that are more concentrated require substantive
resolution of equivocality in decision making to achieve
gains in patient satisfaction.
Our research makes a number of contributions. First,
the literatures in operations, healthcare, policy, and
information systems seem to be converging and
showing that early investments in health IT can produce
quality and efficiency gains—but often with the caveat
that these benefits are nuanced [9, 22-25]. We contribute
to what scholars [26] contend is the next frontier for this
body of work, which is examining how data extracted
and analyzed from these early IT investments in
healthcare (e.g., EHRs) can improve the quality and
efficiency of healthcare delivery [20]. Second, this work

highlights a potentially useful theoretical framework
for investigating the value of analytics capabilities more
generally (i.e., beyond healthcare), and also identifies
the types of factors that may moderate value (e.g., the
nature of decision making challenges in a particular
setting).
Our empirical approach leverages an eight-year
panel dataset (2007–2014) which we created by
combining several independent sources of data. We
leverage between-hospital and across-time variation in
both the adoption of HA and patient satisfaction to
evaluate the impact of HA on patient satisfaction. We
include hospital and time fixed effects, control for
relevant observables, and perform an assortment of
robustness checks to help address selection in hospital
adoption of HA. Although the scale of our dataset
precludes us from collecting detailed survey data, our
work follows in the tradition of others who have used
OIPT as a theoretical lens through which to examine
uncertainty and equivocality resolution [19, 27, 28].

2. Theory and Hypotheses
In recent years there has been increasing discussion
on the role of analytics in improving healthcare delivery
[20]. Part of the reason that analytics is receiving more
attention is that the technology that collects and stores
clinical data is becoming more mature and is diffusing
more rapidly [29]. Government mandates and
incentives are also increasing uptake: for example, the
HITECH Act [30] now requires that EHRs be used by
all healthcare providers [31]. Even though there is a
wide variety of EHR vendors, what is common across
all of them is the ability to collect and store patient data
in a standardized way. With these rich repositories of
data emerging, analytics can be used in more
meaningful ways, not the least of which is to
demonstrate improved clinical decision making. In
addition, the emergence of accountable care
organizations (ACOs) in recent years has drawn even
more attention to the value proposition of data
analytics. ACOs require hospitals, physician groups,
and other caregivers to come together and offer services
that meet quality goals at a lower cost, tying provider
reimbursement to quality metrics. The collaborative
nature of ACOs requires that analytics be deployed to
help the organization use resources “as efficiently as
possible in a population perspective” [32, p. 7].
Despite significant potential value from these
investments, several factors suggest that investment in
HA may provide only some of its total potential value,
and what value is reaped may be nuanced or
heterogeneous. First, recent reports on the adoption of
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analytics in healthcare note that hospitals are still in the
early stages of using clinical analytics and very limited
information exists regarding the actual use of
technologies that provide these capabilities [32, 33]. In
particular, while long-term value in HA investments
may lie in advanced data-driven prediction and decision
making that meaningfully augment highly complex
clinical care, most hospitals are currently focused on
capabilities revolving around simply viewing and
reporting on their existing data. One study found that
83% of providers report looking for analytics tools that
“organize, analyze, and visualize” clinical, as well as
financial and operational data [34]. That study also notes
that most providers are seeking analytics vendors with
“tools that provide clinical quality reporting.”
Second, providers have been skeptical about the
evolving role of analytics capabilities in healthcare,
even with the existing functionality offered by current
tools. For instance, some clinicians and researchers
argue that “human intuition . . . shouldn’t be underrated”
in clinical decision making and that “a computer may
become a second opinion” but would not supplant
clinical decision making in most contexts [35].
Similarly, others argue that “both the simplest tasks and
the most complicated ones require people” and “humans
are still superior at working with, and caring for others
humans” as well as for grasping nuance and uncertainty
[36]. A recent study found evidence of “algorithm
aversion” where humans have a strong preference for a
human decision maker, even when the human is
objectively less accurate than an information system
[21]. The study found that people lose confidence more
quickly in an algorithm relative to a human after seeing
them make the same mistake.
This understanding of the current state of healthcare
analytics capabilities and use guides our subsequent
theoretical development, which focuses on how HA
capabilities can impact patient satisfaction and what
factors moderate this effect.

2.1. Theoretical Model
The fundamental premise of OIPT is that the goal in
organizational design is for firms to process information
to reduce uncertainty [2]. Uncertainty can be defined as
the difference between the amount of information
required to perform the task and the amount of
information already possessed by the organization [2, p.
36-37]. OIPT proposes that mechanisms such as
standardized procedures and hierarchical referrals are
appropriate for low-uncertainty environments, whereas
computerized information systems and lateral relations
are more appropriate for high-uncertainty environments.
Subsequent refinements to OIPT proposed that firms
process information to reduce not only uncertainty but

also equivocality [1]. In contrast to uncertainty, which
materializes from a lack of information, equivocality is
driven by ambiguity rather than insufficient
information [1]. Equivocality primarily occurs because
of a lack of understanding caused by ambiguity,
absence of problem structure, and little to no precedent
for a problem [37].
Applying OIPT to the context of healthcare
delivery, healthcare providers can improve patient
outcomes if they process information in ways that
reduce uncertainty and equivocality in clinical settings
[2, 28]. However, literature also suggests that reducing
equivocality in clinical settings may require
significantly richer information processing and much
more meaningful use of that information relative to
what is required for reducing uncertainty [1, 19]. For
instance, scholars suggest that “certain types of
information processing mechanisms (such as
computerized information systems and, by implication,
systems with integrated data) provide large amounts of
information and can thus help reduce uncertainty.
However they are not as rich a source as other
information processing mechanisms (such as face-toface meetings) and thus are not as effective in reducing
equivocality” [19, p. 298].
Taking into account our prior discussion of the
current state of HA adoption and how these tools are
likely to be used, we extend this line of argumentation
to HA and suggest that current capabilities of HA
centered on the synthesis and aggregation of diverse
and complex information would be well suited for
reducing uncertainty in clinical (and similar) settings,
but less adept at reducing equivocality. For example,
although there are instances where IBM’s Watson (a
state-of-the-art natural language processing and
analytics tool) helps reduce equivocality by diagnosing
rare or perplexing medical conditions, thereby
attracting interest from popular press [38], in practice
the tool is much more commonly used to reduce
uncertainty in terms of what treatments are safest and
effective for a particular patient with an already known
diagnosis [39, 40]. Moreover, uses of HA that augment
existing processes to reduce uncertainty may be less
threatening to physicians’ autonomy and require less
trust compared to more involved uses of HA that reduce
equivocality (e.g., correcting a misdiagnosis by
physicians), making gains from reduced uncertainty
more likely to be realized. This suggests that even if
complex analytics capabilities are available,
phenomena like the “algorithm aversion” described
previously may result in limited use of the tool to
actually reduce equivocality [21].
We conjecture that in healthcare environments
generally replete with decision uncertainty [18, 27], HA
will improve patient satisfaction, on average, because
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of its significant potential to process information and
resolve uncertainty. However, because HA is more
likely to be effective at reducing uncertainty relative to
equivocality, the effect of HA is argued to emerge
unevenly across different clinical settings. This is
because the uncertainty reductions that HA offers may
be less valuable in clinical settings that also require the
resolution of equivocality to achieve improvements in
patient satisfaction.
We argue that two factors (clinical complexity and
hospital concentration) moderate the extent to which
resolution of equivocality (as opposed to uncertainty) is
key to achieving gains in patient satisfaction. Our
outcome is a multi-dimensional patient satisfaction
measure and we present our research model in Figure 1.

Complexity
Healthcare
Analytics

Patient
Satisfaction

Uncertainty
Reduction
Mechanism

Controls
Concentration

Value of HA is
moderated by the need to
reduce Uncertainty versus
Equivocality

Figure 1. Research model

2.2. Impact of healthcare analytics on patient
satisfaction
We propose a beneficial main effect of HA
investments on patient satisfaction. Using the
theoretical lens of OIPT, the primary mechanism
through which this happens is the reduction of
information uncertainty. According to OIPT, when there
is a high degree of information uncertainty, one way
organizations deal with this is by increasing the capacity
to process information through investment in
computerized information systems [19]. Healthcare
analytics systems are one form of information system
that can substantially contribute to uncertainty reduction
because of their capabilities in data gathering and
analysis, which ultimately can influence patient
outcomes. These benefits may be substantial in a hectic
and dynamic healthcare environment where uncertainty
in decision making can emerge in many of the processes
and activities necessary to the provision of effective
clinical care [17, 18]. Prior work has asserted that

uncertainty is possibly the most important single
influence on physician behavior [18, 27]. This work
highlights a variety of sources of uncertainty in the
delivery of healthcare, including the lack of information
on the probabilities of treatment outcomes (even under
controlled circumstances) and a disconnect between the
utility of the physician—who makes vicarious
decisions—and patient’s utility [17, p. 517]. Thus, our
contention is that HA will reduce uncertainty and offer
value in many ways including but not limited to
reductions in medical errors, improved coordination of
care, better decision making, and improved
communication.
Because extant research on the effect of HA is
limited, we also interviewed several clinicians and
senior administrators at hospitals and health systems.
These informants conveyed a number of powerful
anecdotes about HA and how its use reduces
uncertainty and contributes to patient satisfaction. One
respondent noted that the use of clinical analytics has
contributed to his hospital’s understanding of clinical
processes and where bottlenecks occur, allowing the
staff to better coordinate care for patients. This
improved coordination of care has enabled them to
dramatically reduce wait times of patients prior to being
seen by a clinician and after the first encounter, which
he noted is a key factor in patient satisfaction. Another
interviewee from a very large health system said they
use a population health management tool to look at ‘big
data’ and synthesize it to identify at-risk subgroups.
Then they attempt to engage these subgroups with
targeted wellness approaches. We highlight these as
instances where HA is used primarily to reduce
uncertainty in clinical settings, whether it be around
identifying processes that are inefficient or with respect
to how to best tailor treatment for individual patients.
These reductions in uncertainty in clinical settings
should result in positive impacts, on average, on patient
satisfaction. Therefore, we hypothesize that:
H1: The use of healthcare analytics will be
positively related to patient satisfaction.

2.3. Moderating effect of complexity and
concentration
We will present arguments suggesting that hospitals
that treat low-complexity patients or are highly
diversified will benefit from HA adoption since they
can achieve substantial gains in patient satisfaction
largely by reducing uncertainty. In contrast, hospitals
that treat highly complex patients and/or are clinically
specialized (i.e., high concentration) also require
resolution of equivocality to achieve improved patient
satisfaction, diminishing the benefit these hospitals
receive from the adoption of HA.
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2.3.1. Complexity. Complexity in managing healthcare
arises from the range and severity of the patient
population catered to by the hospital. This is
operationalized using the industry-standard case mix
index (CMI) [41], with higher CMI indicating more
complex cases. Although there exists significant
variation between hospitals in the complexity and nature
of patients they see [42], no study has examined the
moderating role of complexity as it relates to the use of
analytics in healthcare. We examine this question and
contend that the complexity of the patients treated in a
hospital may be an important moderator of realizing
value from HA capabilities.
Case complexity ranges on a continuum: on one end
of the spectrum are hospitals that generally treat lowcomplexity patients who are characterized by fewer
comorbidities and less severe medical conditions. Care
for these patients is less ambiguous since providers may
be confident of underlying causes of the patients’
symptoms and what general procedures are needed to
properly treat the patient. In these instances, decisions
and procedures that might be critical to patient
satisfaction are more systematic and predictable,
suggesting that equivocality is not a critical factor in
driving improved patient satisfaction. This does not
mean that the care of lower complexity patients is
trivial; in fact, OIPT suggests that these types of
decisions and procedures can benefit significantly from
reductions in information uncertainty [19].
As hospitals move along the continuum towards the
treatment of higher complexity patients, the value of
reduction in uncertainty becomes less pronounced and
resolution of equivocality matters more. Highcomplexity patients often have multiple medical
conditions, rare diseases, and/or difficult-to-treat
conditions, requiring providers to focus on reducing
equivocality to deliver high quality care. To illustrate,
consider an alternative scenario where a provider
interacts with a patient with a set of symptoms that are
not definitive of any specific condition, leaving the
provider unsure about the steps to take to both diagnose
and treat the patient. In this case, information processing
mechanisms (potentially non-IS mechanisms) that
reduce equivocality become critical to providing the
best care for the patient. OIPT would suggest that
consultation with other providers and specialists might
be particularly useful in these cases [19]. Consistent
with other work [19], if the equivocality in this case
cannot be addressed, any information processing
capabilities that reduce uncertainty will be of less value.
For example, providers may try to treat patients for a
variety of things simultaneously, limiting the value of
HA that, for example, provides deep insights into
tailored treatment when the cause is clear. Overall, this

suggests that as hospitals move towards treating higher
complexity patients, reducing equivocality, not
uncertainty, will be most critical for improving patient
satisfaction—but HA is not well suited to reducing
equivocality. Drawing on our previous arguments that
HA capabilities are likely to be highly valuable when
uncertainty rather than equivocality is a key challenge,
this suggests that hospitals that deal mostly in lowcomplexity patients would reap more value from HA
investments relative to hospitals that deal in higher
complexity patients. Formally, we hypothesize:
H2: Because of the uncertainty reduction capabilities
of HA, the effect of HA on patient satisfaction will be
greater in lower complexity hospitals.
2.3.2. Concentration. Another factor we consider is
concentration—or more generally, the concept of
organizational ‘focus’—which refers to the allocation
of hospital resources toward specific offerings of
services [43, 44]. Low concentration signifies
diversification of functions performed, while a high
level of concentration indicates that the majority of
resources are focused on only a small number of
functions [43]. In the healthcare setting, higher
concentration indicates that the hospital allocates a
significant portion of its resources to a smaller number
of clinical areas. For example, some hospitals are very
specialized with the majority of their care efforts
focused on a specific clinical context (e.g., cancer, heart
disease, women’s or children’s care), while others are
more general and treat a wide range of patients and
conditions. Similar to complexity, we argue that
concentration impacts the extent to which reducing
uncertainty or equivocality matters for improved
patient outcomes and satisfaction.
We first consider hospitals that are concentrated and
focus on a specific set of clinical areas. Highly
concentrated hospitals are likely to be marked by high
population homogeneity and a deep institutional
knowledge in their specific area of focus; this includes
specialized experience of their providers as well as a
robust understanding of processes to efficiently provide
their specific type of care. Their deep knowledge and a
more homogenous patient population suggest that
uncertainty may be less of a factor in driving improved
patient outcomes and satisfaction for these hospitals.
On the other hand, equivocality may be a major factor
for these hospitals. In particular, the patients they see
may have very specific needs, suggesting that they
would commonly have to deal with less structured,
ambiguous care. Relatedly, providers in specialized
hospitals may be experts in a particular clinical area,
leading them to either trust their own experience and
expertise over HA tools or to perceive existing tools as
too rudimentary to be of use to them. Overall, we
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contend that achieving gains in patient satisfaction for
highly concentrated hospitals depends more on
resolution of equivocality than uncertainty.
As we move down this continuum towards hospitals
that are more diverse in their focus (i.e., less
concentrated), the need to reduce equivocality versus
uncertainty starts to shift. Unlike highly concentrated
hospitals, hospitals that split their focus across a number
of care areas are less likely to develop deep knowledge
or competence in any specific area of care. Without deep
institutional investment into standard processes of care
or tailored resources for each of their clinical areas, it
becomes more likely that clinicians (even those
specializing in that area of care) will face more
uncertainty in the daily provision of care. For instance,
compared to a pediatrician at a children’s hospital, a
pediatrician at a diversified hospital may have fewer
colleagues to draw insights from, less institutional
knowledge to support their activities, and less training
to handle various clinical needs of even patients who
require standard care (i.e., when equivocality is low). At
the same time, resolution of equivocality may be less
important for improving patient satisfaction in
diversified hospitals. Equivocality may simply be lower
since patients with highly unstructured care needs may
seek concentrated facilities that can address their
specific needs better. For these reasons, we contend that
reducing uncertainty in diverse hospitals (i.e., low in
concentration) will result in substantial gains in patient
satisfaction. Leaning on our previous arguments that
HA capabilities are likely to be highly valuable when
uncertainty is a key challenge, this suggests that
hospitals that are high in concentration would reap less
value from HA investments relative to hospitals that are
more diverse. Formally, we hypothesize:
H3: Because of the uncertainty reduction capabilities
of HA, the effect of HA on patient satisfaction will be
greater in low concentration hospitals.

the hospital. All of these dimensions are measured on a
scale of 0–100. We take the average of patients’
assessments across all ten of these dimensions for a
given hospital to generate our annual measure of patient
satisfaction. To identify hospital analytics capabilities,
we leverage data from the annual HIMSS Analytics
Database (HADB) which captures various dimensions
of hospital technology capabilities. Specifically, we
focus on hospital reports of investment in “Business
Intelligence” or “Data Mining” and designate a hospital
as having Clinical Healthcare Analytics (HA)
capabilities if it reported investing in clinically focused
business intelligence and data mining.
We also leverage diverse datasets to measure the
factors that may moderate the impact of analytics
capabilities on patient satisfaction: Complexity and
Concentration. Complexity is measured using annual
data from the Centers for Medicare and Medicaid
Services (CMS) on a given hospital’s CMI, which
reflects the mix of patients in higher versus lower
severity diagnosis-related groups (DRGs) [41].
We measure our other moderator, Concentration, by
drawing upon prior work [43], which calculates a
Herfindahl-Hirschman Index (HHI) for a given hospital
that captures whether a hospital has a narrow or widely
varied clinical focus. Specifically, we leverage Hospital
Compare data to identify the number of medical cases
in the hospital across ten Major Diagnostic Categories
(MDC), based on the 70 most common DRGs as
designated by CMS. Following the method for
computing the HHI [43], we first tally the total number
of cases in these MDCs for a hospital i (TotalCasesi).
Then we calculate the proportion that any one MDC j
accounted for relative to the total cases. These values
are then squared and summed to generate a value
between 0 and 1. Hospitals with higher values of
HHIConc represent those that focus on one or a few
clinical areas, whereas hospitals with lower values offer
a diverse set of clinical areas.

3. Data
Our empirical approach leverages an eight-year
panel dataset (2007–2014). Our central outcome
measure of patient satisfaction comes from the Hospital
Consumer Assessment of Healthcare Providers and
Systems (HCAHPS) survey on patient satisfaction.
These data are collected annually for the vast majority
of hospitals in the U.S. and include ten questions
capturing patient perspectives on care across several
topics: communication with doctors, communication
with nurses, responsiveness of hospital staff, pain
management, communication about medicines,
discharge information, cleanliness of the hospital
environment, and quietness of the hospital environment,
an overall hospital rating and if they would recommend
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4. Main Estimation and Results
We estimate the various relationships in our model
using econometric models for panel data. Specifically,
we estimate an OLS, panel fixed effects model including
both time and hospital fixed effects and robust standard
errors. Our main specification is:
PatientSatisfactionit = β1 *HAClinicalit +
γ*CONTROLSit + θi + λ t+ µit
PatientSatisfactionit is the average patient
satisfaction for hospital j at time t. HAClinicalit is a
dichotomous variable indicating whether a hospital i at
time t reported having adopted clinically focused data
analytics capabilities. In our main estimation, we treat
this adoption decision as binary but our results are
robust to the relaxation of this assumption. In addition
to our main variables of interest, we include a vector of
controls to account for other relevant observables,
potentially associated with patient satisfaction and a
hospital’s choice to pursue analytics capabilities. First,
we include a control for the adoption of other health IT
that may influence patient satisfaction and also correlate
with analytics capabilities (EHRAdoptionit and
Portalsit). We also include a number of controls focused
on hospital characteristics. Finally, we include a
measure of market competition using the HHI index for
hospitals in a hospital referral region based on hospital
staffed beds. This control is useful if highly competitive
markets care more about patient satisfaction and are also
more likely to pursue clinical analytics capabilities.
We also include hospital and time fixed effects
(represented by θi and λt, respectively); μit is the error
term. Hospital fixed effects allow us to control for timeinvariant factors that could simultaneously drive the
emergence of analytics capabilities and changes in
patient satisfaction. For instance, it may be the case that
academic hospitals are more likely to invest in analytics
and also have more of a focus on patient-centric care.
Because healthcare markets do not change very quickly
over time, hospital fixed effects are a key dimension of
identification in our estimated model. Time fixed effects
allow us to control for time trends in our data and any
shocks that impact all hospitals in a given year; for
example, any legislation that applies nationally would
be captured by our time fixed effects.
In an extension of our main model, we estimate the
impact of our two main moderating variables by
interacting them with our measure of HA capabilities.
Specifically, we consider our first moderating factor,
Complexity, captured by the case mix index of hospital
i at time t (Complexityit), and our second moderating
factor, Concentration, captured by the hospital-specific
HHI derived from its mix of clinical activities
(HHIConcit). This extended model allows us to tease out

any differential effects of HA under different levels of
patient complexity and hospital concentration.
PatientSatisfactionit = β1 *HAClinicalit
+δ1*HAClinicalit*Complexityit
+δ2*HAClinicalit*Concentrationit +
γ*CONTROLSit + θi + λ t+ µit

4.1. Results
We first evaluate the main effect of HA on patient
satisfaction (hypothesis 1) using a random effects
model (Table 1, column 1), which identifies initial
evidence of a positive impact of HA on patient
satisfaction (βHAClinical = .468, p<.01). We then estimate
a fixed effects model which replicates our random
effects model with the addition of hospital fixed effects
that account for time-invariant hospital factors that may
bias our estimation (column 2). We find consistent
results with our random effects estimation (βHAClinical
=.410, p<.01), confirming evidence for a positive main
effect of clinical analytics capabilities on patient
satisfaction, providing support for H1. This positive and
significant result speaks to HA’s capabilities, on
average, to positively impact hospital processes and
activities related to patient satisfaction.
Table 1. Main results
VARIABLES
HAClinical
HAClinical*
Complexity
HAClinical*
HHIConc
EHRAdoption
Portals
NoStaffedBeds
NoOutVisits
NoERVisits
NoOperatRooms
NoPatientDays
Complexity
MarketCompet
Constant
R2
Observations
HOSPITAL FE
YEAR FE

Random
Effects
0.468***
(0.101)

Fixed
Effects
0.410***
(0.104)

0.0425*
(0.0219)
0.259***
(0.0800)
-0.0073***
(0.000650)
-1.30e-07
(1.75e-07)
-5.4e-07***
(1.73e-07)
0.0329***
(0.0103)
1.67e-09*
(9.61e-10)
1.241***
(0.261)
3.391***
(0.675)
70.14***
(0.395)
.315
14,677
NO
YES

0.0494**
(0.0221)
0.247***
(0.0824)
-0.00121
(0.00118)
-1.33e-07
(1.80e-07)
-2.07e-07***
(7.54e-08)
0.0163
(0.0106)
1.07e-09*
(6.48e-10)
0.618*
(0.352)
-1.640
(1.441)
70.74***
(0.643)
.320
14,677
YES
YES

Full
Model
2.608***
(0.783)
-0.902***
(0.340)
-2.414
(1.618)
0.0496**
(0.0221)
0.261***
(0.0825)
-0.00106
(0.00120)
-1.15e-07
(1.84e-07)
-2.1e-07***
(7.49e-08)
0.0175
(0.0107)
9.84e-10
(6.50e-10)
0.622*
(0.355)
-1.635
(1.442)
70.67***
(0.655)
.323
14,542
YES
YES
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With evidence of a main effect of HA on patient
satisfaction, we turn to the potential moderating role of
hospital complexity and concentration (column 3).
Estimating our full model, we find that the largest gains
from clinical analytics capabilities accrue to hospitals
with low clinical complexity but broad clinical
concentration. Specifically, we see that these gains
diminish as clinical complexity increases, with a large
and significant coefficient on the interaction of
HAClinical and Complexity (βHAClinical*Complexity = -0.902,
p<.001—H2 supported) and a directionally consistent
(but insignificant) coefficient on the interaction between
HAClinical and Concentration (βHAClinical*HHIConc = 2.414, not significant—H3 not supported). Overall, our
results suggest that hospitals at the lower end of the
complexity spectrum may see as much as a 2-point gain
in patient satisfaction from analytics implementation.
Yet, it is surprising that concentration did not moderate
the relationship. As noted in our theoretical justification,
there were ex ante reasons to believe that more
diversified hospitals, which are more siloed and have
less depth in any given field of care, might benefit more
from uncertainty reductions and thus reap more benefit
from analytics. In an effort to better understand the nonsignificant result for concentration, we partitioned our
analysis by large and small hospitals (using a median
split). We conjectured that the factors that drive
information uncertainty in diversified hospitals may be
more pronounced in larger hospitals because
information silos may be pronounced. We reanalyzed
the data and found a moderating effect of concentration
is significant and negative in large hospitals (table
removed due to space constraints). We also conducted
robustness checks and performed endogeneity checks
that were removed to conserve space.

5. Discussion
We evaluate the effect of healthcare analytics
following guidance provided through the application of
OIPT and find a significant main effect of analytics on
patient satisfaction as well as meaningful evidence of a
theoretically relevant moderator of this effect. At the
same time, we acknowledge that our study has some
important limitations. Our measure of clinical analytics
is admittedly coarse, but we do find our results to be
robust to a variety of conditions and our dataset is
extremely large relative to the population of hospitals.
Moreover, this problem is not unique to analytics as the
same issue existed in early studies of EHRs where only
three or fewer technologies made up a suite [29].
Another limitation is that we argue that OIPT
provides the theoretical mechanism through which HA
acts on patient satisfaction and that complexity and

concentration have a moderating effect on this
relationship. Since we do not directly measure
information processing, we cannot conclude that it is
the only theoretical mechanism that could be used to
inform the relationships we observe. We believe our
argumentation to be compelling, but there is a chance
that other theoretical frameworks could similarly
inform the value of analytics capabilities in healthcare
settings. These limitations are largely due to data
constraints, which we hope to address in future works
by collecting primary data on actual information
processing capacity in a specific clinical setting.
We first discuss the main effect of HA on patient
satisfaction, which yielded a regression coefficient of
0.468. While small, there is reason to be optimistic
about this magnitude. First, the effect size increases by
more than two points (regression coefficient of 2.608 in
Table 1, column 3) when considering the moderating
effects of complexity and concentration. Second,
industry observers note that the cost of low patient
satisfaction scores is non-trivial and it is extremely
difficult to overcome perceptions of poor care [45, 46].
Now that CMS provides reimbursements based on
patient satisfaction scores, this has become an even
greater strategic issue for hospitals [46].
Our results confirm our second hypothesis that
hospitals with high-complexity cases may see
diminished gains from analytics capabilities, at least in
terms of patient satisfaction. We argue that this may
occur due to the equivocality that results from treating
highly complex patients. It is more likely that hospitals
are seeking information about general trends or simply
using basic features of HA that provide elementary
information rather than condition-specific complex data
about complicated cases. This would explain why lower
complexity hospitals have greater gains from HA. But
it does highlight a more general and critical point. As
analytics capabilities evolve to become more robust, it
is possible, and maybe even likely, that value will
increase for higher complexity cases in the long term.
As a result, we think it is important for future
researchers to investigate whether the effect of
complexity may differ as analytics capabilities mature.
In hindsight it is not surprising that we did not find
a significant effect of concentration in the full
population of hospitals. To the extent that the value
from analytics grows exponentially with the amount of
data available, it is expected that it would be larger
hospitals that reap the most benefits, at least in the short
term. Over time, as smaller hospitals accrue larger data
stores, they are likely to benefit as well. It is important
to recognize that analytics capabilities are still regarded
as new and researchers typically do not have access to
actual use data. Until these data become available, it is
important to take preliminary steps toward
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understanding the value proposition of data analytics in
general, but it is possible that we are expecting ‘too
much too soon’ in terms of understanding the complex
dynamics associated with integrating analytics into
long-established workflows.

6. Conclusion
Our study is a first attempt at theorizing how
hospitals use analytics to reap benefits. The theoretical
frame of OIPT provides the basis for our argument that
HA is an uncertainty-reducing mechanism that impacts
patient satisfaction. We proposed a nuanced moderating
role of complexity of patient cases and concentration
and while the conditional effect of concentration is
somewhat unclear, the main effect of HA on satisfaction
is unambiguously positive—suggesting that analytics is
reducing uncertainty with healthcare delivery tasks and
improving patient satisfaction. Also, the conditional
effect of complexity on value from analytics seems
defensibly negative, presumably via its theorized impact
of increasing uncertainty relative to the current state of
analytics capabilities. The findings are important first
steps toward investigating how value can be extracted
from data analytics.
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